Composition and method for treatment of tumors

Details for Australian Patent Application No. 2007276793 (hide)

Owner Sanofi-Aventis

Inventors August, Paul; Huang, Waan Jeng; Natesan, Sridaran; Lieberman, Soyan

Agent Watermark

Pub. Number AU-A-2007276793

PCT Pub. Number WO2008/014296

Priority 60/833,879 28.07.06 US

Filing date 25 July 2007

Wipo publication date 31 January 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 February 2009 PCT application entered the National Phase

  PCT publication WO2008/014296 Priority application(s): WO2008/014296

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007276804-Inhibitors of undecaprenyl pyrophosphate synthase

2007276788-Compounds and compositions as hedgehog signaling pathway modulators